12/13/2024 8:00 PM | ADC Therapeutics (Issuer) Green Jeremy (Reporting) RedCo II Master Fund, L.P. (Reporting) Redmile Group, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 7:37 PM | ADC Therapeutics (Issuer) Carmona Jose (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 7:39 PM | ADC Therapeutics (Issuer) Kallebo Lisa Michelle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 7:42 PM | ADC Therapeutics (Issuer) Zaki Mohamed (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 7:35 PM | ADC Therapeutics (Issuer) GRAHAM PETER J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 7:30 PM | ADC Therapeutics (Issuer) MALLIK AMEET (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2024 8:00 PM | ADC Therapeutics (Issuer) Green Jeremy (Reporting) RedCo II Master Fund, L.P. (Reporting) Redmile Group, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
11/14/2024 8:00 PM | ADC Therapeutics (Subject) Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/13/2024 3:13 PM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 7:58 AM | ADC Therapeutics (Subject) Prosight Management, LP (Filed by)
| Form SC 13G/A | |
11/13/2024 7:30 AM | ADC Therapeutics (Subject) Prosight Management, LP (Filed by)
| Form SC 13G/A | |
11/07/2024 9:44 AM | ADC Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024 6:54 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 3:35 PM | ADC Therapeutics (Filer)
| Form DEF 14A | |
09/23/2024 3:39 PM | ADC Therapeutics (Filer)
| Form DEFA14A | |
08/13/2024 11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
08/06/2024 3:26 PM | ADC Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/06/2024 9:06 AM | ADC Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/06/2024 6:37 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2024 7:00 PM | ADC Therapeutics (Issuer) Green Jeremy (Reporting) RedCo II Master Fund, L.P. (Reporting) Redmile Group, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:40 PM | ADC Therapeutics (Issuer) Monges Viviane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:41 PM | ADC Therapeutics (Issuer) Hug Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:43 PM | ADC Therapeutics (Issuer) BIZZARI JEAN-PIERRE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:45 PM | ADC Therapeutics (Issuer) Azelby Robert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:29 PM | ADC Therapeutics (Subject) Azelby Robert (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024 8:30 PM | ADC Therapeutics (Subject) Squarer Ron (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024 8:35 PM | ADC Therapeutics (Issuer) Squarer Ron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:37 PM | ADC Therapeutics (Issuer) Sandor Victor (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:38 PM | ADC Therapeutics (Issuer) Pfisterer Thomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 8:26 PM | ADC Therapeutics (Subject) BIZZARI JEAN-PIERRE (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024 8:28 PM | ADC Therapeutics (Subject) Sandor Victor (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 4:44 PM | ADC Therapeutics (Issuer) BIZZARI JEAN-PIERRE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:46 PM | ADC Therapeutics (Issuer) Azelby Robert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:37 PM | ADC Therapeutics (Issuer) Pfisterer Thomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:40 PM | ADC Therapeutics (Issuer) Hug Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:23 PM | ADC Therapeutics (Issuer) Monges Viviane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:25 PM | ADC Therapeutics (Issuer) Squarer Ron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:29 PM | ADC Therapeutics (Issuer) Sandor Victor (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 2:33 PM | ADC Therapeutics (Issuer) Pfisterer Thomas (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/14/2024 11:32 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:06 PM | ADC Therapeutics (Issuer) MALLIK AMEET (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) It’s here. This is the moment we’ve been waiting for.
The next 3-6 months in crypto will be absolutely life-changing for those who are prepared.
Why? Because altcoin prices are about to explode. >> Register for the Workshop Now |
05/07/2024 3:06 PM | ADC Therapeutics (Subject) MALLIK AMEET (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024 5:51 AM | ADC Therapeutics (Filer)
| Form 424B5 | |
05/06/2024 5:38 AM | ADC Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024 5:29 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2024 8:31 PM | ADC Therapeutics (Subject) Oaktree Capital Group Holdings GP, LLC (Filed by)
| Form SC 13G | |
04/26/2024 3:21 PM | ADC Therapeutics (Filer)
| Form DEFA14A | |
04/16/2024 3:16 PM | ADC Therapeutics (Filer)
| Form PRE 14A | |
04/09/2024 3:06 PM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/15/2024 3:11 PM | ADC Therapeutics (Filer)
| Form 424B3 | |
03/15/2024 3:11 PM | ADC Therapeutics (Filer)
| Form 424B3 | |
03/14/2024 11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/14/2024 11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/14/2024 11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/13/2024 3:17 PM | ADC Therapeutics (Filer)
| Form POS AM | |
03/13/2024 3:14 PM | ADC Therapeutics (Filer)
| Form POS AM | |
03/13/2024 2:19 PM | ADC Therapeutics (Filer)
| Form ARS | |
03/13/2024 11:25 AM | ADC Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/13/2024 6:39 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 8:15 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 8:47 AM | ADC Therapeutics (Subject) Prosight Management, LP (Filed by)
| Form SC 13G/A | |
02/12/2024 9:13 AM | ADC Therapeutics (Subject) ASTRAZENECA PLC (Filed by) ASTRAZENECA PLC (Filed by)
| Form SC 13G/A | |
02/09/2024 8:50 PM | ADC Therapeutics (Issuer) Green Jeremy (Reporting) RedCo II Master Fund, L.P. (Reporting) Redmile Group, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 8:45 PM | ADC Therapeutics (Issuer) Green Jeremy (Reporting) RedCo II Master Fund, L.P. (Reporting) Redmile Group, LLC (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/24/2024 7:00 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 3:30 PM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 6:15 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 6:00 AM | ADC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2024 7:00 PM | ADC Therapeutics (Issuer) Pfisterer Thomas (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:01 PM | ADC Therapeutics (Issuer) Sandor Victor (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:02 PM | ADC Therapeutics (Issuer) Squarer Ron (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:04 PM | ADC Therapeutics (Issuer) Hug Peter (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:05 PM | ADC Therapeutics (Issuer) Zaki Mohamed (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:06 PM | ADC Therapeutics (Issuer) Azelby Robert (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:07 PM | ADC Therapeutics (Issuer) BIZZARI JEAN-PIERRE (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:08 PM | ADC Therapeutics (Issuer) GRAHAM PETER J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:09 PM | ADC Therapeutics (Issuer) Carmona Jose (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 7:10 PM | ADC Therapeutics (Issuer) Monges Viviane (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 6:56 PM | ADC Therapeutics (Issuer) Rivers Tyrell (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 6:58 PM | ADC Therapeutics (Issuer) Kallebo Lisa Michelle (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2024 6:59 PM | ADC Therapeutics (Issuer) MALLIK AMEET (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |